SEC Form 4 · accession 0001209191-15-041564
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Condella Jr.
Officer — President & CEO
Period of report
May 11, 2015
Accepted (ET)
May 12, 2015 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| $0.01 par value Common Stock | May 11, 2015 | M | 9,375 | $4.95 | A | 74,720 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $4.95 | May 11, 2015 | M | 9,375 | D | Mar 1, 2014 | Mar 1, 2020 | $0.01 par value Common Stock | 9,375 | 9,375 | D |
Remarks
Exercise of 9,375 vested stock options to hold shares.